Maiwald at LSPN North America Fall 2026 in San Francisco | November 2–3

Maiwald will once again take part in one of the leading IP conferences for the life sciences industry and is proud to support LSPN North America Fall 2026 as a Gold Sponsor.

The Life Sciences Patent Network (LSPN) conference in San Francisco brings together leading experts from the pharmaceutical, biotechnology, and medical device industries to discuss current developments and strategic challenges in intellectual property.

We are delighted that Dr. Eva Ehlich and Dr. Anja Fux will participate in a roundtable discussion on “Patenting around clinical development in Europe” on the first day of the conference. The discussion will focus on strategic considerations surrounding patent protection in the context of clinical development in Europe. In addition, Dr. Dirk Bühler will be attending to connect and exchange insights with the international life sciences IP community.

As the innovation landscape continues to evolve, LSPN provides an important platform for discussing emerging legal developments and forward-looking IP strategies. The conference offers an opportunity to bring together different perspectives and explore approaches to the complex challenges facing the life sciences sector.

We look forward to engaging discussions, fresh perspectives, and valuable exchanges with colleagues from across the international life sciences IP community in San Francisco.